We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Light Switch Added to Oligomers Improves Precision of Gene-Blocking Studies

By LabMedica International staff writers
Posted on 23 May 2012
Print article
Scientists collaborating with a company that synthesizes antisense oligomers have tested a new Ultraviolet (UV) light-activated on-off switch linked to these molecules. Based on initial testing, the enhanced oligomers promise to deliver detailed insights from studies in fields such as developmental biology and neuroscience.

The team described the advancement in a paper published May 1, 2012, in the journal Development. Philip Washbourne, professor of biology at the Institute of Neuroscience of the University of Oregon (Eugene, USA), says the paper is a proof-of-concept on an idea he discussed with scientists at Gene Tools LLC (Philomath, OR, USA), which produces “Morpholino” oligonucleotides, a form of synthetic short-chain antisense (or sense) oligomers used to block gene function by RNA-binding.

Biologists have been using morpholinos in zebrafish and other model organisms to study development, but the molecules remained in the "on" (active) state. Gene Tools introduced a light-sensitive linker, allowing researchers to control the photo-morpholinos temporally and spatially — even leaving one "on" in one cell and "off" in an adjacent cell — with a pinpoint UV laser beam.

University of Oregon researchers in Westbourne’s lab, led by research associate Alexandra Tallafuss, were challenged to give the new molecules a test run in zebrafish. "Now we can turn them on and off," Prof. Washbourne said, "you can insert them and then manipulate them to learn just when a gene is important, and we learned two things right away." Researchers have known that if the "no tail" gene is blocked in development, zebrafish fail to grow tails. With the new photo-cleavable morpholinos, they discovered that the no-tail gene does not need to produce protein for tail formation until about 10 hours, or very late, into an embryo's development. Secondly, the researchers looked at the gene sox10 that is vital in the formation of neural crest cells. "Again, we found that sox10 is not needed as early in development as theorized," Prof. Washbourne said.

"These light-sensitive molecules significantly expand the power and precision of molecular genetic studies in zebra fish," said Robert Riddle, a program director at the National Institute of Neurological Disorders and Stroke (NINDS); "Researchers from many fields will be able to use these tools to explore the function of different genes in embryonic regions, specific cell types, and at precise times in an animal's lifespan."

Related Links:
Institute of Neuroscience, University of Oregon
Gene Tools LLC


New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Automated Blood Typing System
IH-500 NEXT
New
Adenovirus Detection Kit
REALQUALITY RQ-ADENO
New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Immunology

view channel
Image: An immune response is initiated when an antigen-presenting cell (pink) presents foreign material to a T-cell (blue) (Photo courtesy of JAX)

Advanced Imaging Method Maps Immune Cell Connections to Predict Cancer Patients Survival

A growing tumor is influenced not only by the tumor cells themselves but also by the surrounding tissue, which alters its biology. Immune cells communicate by transferring vital signaling proteins to their... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: SCOPE IO has shown promise in predicting immunotherapy response in rare cancer patients (Photo courtesy of Lunit)

AI-Powered Whole-Slide Image Analyzer Predicts Immunotherapy Response for Rare Cancer Patients

Immunotherapy, especially immune checkpoint inhibitors like pembrolizumab, has become a groundbreaking treatment for cancer patients. However, not all patients respond the same way to this therapy, and... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.